ARCHIVES

MSKCC oncologist settles insider trading case with SEC.

This article is from The Cancer Letter archive.

Vol. 31 No. 41 | November 11, 2005

Download PDF Visit The Full Archive

Related Articles

ODAC Votes For Approval Of PegIntron For Melanoma, Votrient For Renal Cancer

October 9, 2009

Guest Editorial: As Sequestration Becomes More Likely, Health Groups Must Make Themselves Heard

February 22, 2013

Wilms’ Tumor Survivors At High Risk Of Heart Failure

April 27, 2001

Huebner Retires, Named Scientist Emeritus

November 19, 1982

Phase III Vaccine Trial Fails To Improve Overall Survival

October 25, 2013

FDA Committee IK IL-2/LAK For Modified Group C

May 1, 1987